Location History:
- Cambridge, MA (US) (2016 - 2023)
- Boston, MA (US) (2012 - 2024)
Company Filing History:
Years Active: 2012-2024
Title: The Innovative Contributions of Jared Gollob
Introduction
Jared Gollob is a prominent inventor based in Boston, MA (US), known for his significant contributions to the field of biotechnology. With a total of 11 patents to his name, Gollob has made strides in developing innovative solutions that address critical health challenges.
Latest Patents
Among his latest patents is the invention titled "GNAQ targeted dsRNA compositions and methods for inhibiting expression." This invention focuses on a double-stranded ribonucleic acid (dsRNA) that targets the G-alpha q subunit (GNAQ) of a heterotrimeric G gene, providing methods to inhibit the expression of GNAQ. Another notable patent is "Dosages and methods for delivering lipid formulated nucleic acid molecules," which discloses methods, kits, and devices designed to dose a subject in order to reduce a hypersensitivity response to lipid-formulated nucleic acid molecules, such as RNA.
Career Highlights
Jared Gollob is currently associated with Alnylam Pharmaceuticals, Inc., where he continues to push the boundaries of innovation in the pharmaceutical industry. His work has been instrumental in advancing therapeutic approaches that leverage RNA interference technology.
Collaborations
Throughout his career, Gollob has collaborated with notable colleagues, including Ivanka Toudjarska and David A Bumcrot. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking inventions.
Conclusion
Jared Gollob's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His innovative work continues to pave the way for advancements in medical treatments and therapies.